These compounds may interact with:
5-hydroxytryptamine receptor 1A
Potentially involved in: carcinoma; anxiety disorder; schizophrenia; major depressive disorder; hypoactive sexual desire disorder; bipolar disorder; parkinson's disease; pain agnosia; amnestic disorder; migraine; premature ejaculation; drug psychosis; sudden infant death syndrome; epilepsy; motion sickness; alcohol dependence; sexual dysfunction; substance abuse; personality disorder; neuroleptic malignant syndrome
Disease data sourced from Pharos.